1-3 of 3
Yoel Kloog
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia

Liat Goldberg, Marloes R. Tijssen, Yehudit Birger, Rebecca L. Hannah, Sarah J. Kinston, Judith Schütte, Dominik Beck, Kathy Knezevic, Ginette Schiby, Jasmine Jacob-Hirsch, Anat Biran, Yoel Kloog, Guido Marcucci, Clara D. Bloomfield, Peter D. Aplan, John E. Pimanda, Berthold Göttgens, Shai Izraeli
Journal: Blood
Blood (2013) 122 (15): 2694–2703.
https://doi.org/10.1182/blood-2013-01-477133
Published: 2013
Includes: Supplemental data
Journal Articles

Combining the Ras Inhibitor Salirasib and Proteasome Inhibitors: A Potential Treatment for Multiple Myeloma

Shira Yaari-Stark, Yael Nevo-Caspi, Jasmine Jacob-Hircsh, Gideon Rechavi, MD, PhD, Arnon Nagler, M.D., Yoel Kloog
Journal: Blood
Blood (2010) 116 (21): 1810.
https://doi.org/10.1182/blood.V116.21.1810.1810
Published: 2010
Journal Articles

MODELING and Targeting ERG -INDUCED Acute MYELOID LEUKEMIA (AML).

Gil Smooha, Yehudit Birger, PhD, Liat Goldberg, PhD, Jasmine Jacob-Hirsch, MSc, Ninette Amariglio, PhD, Gideon Rechavi, MD, PhD, Ditsa Levanon, PhD, Yoram Groner, PhD, Anat Taragan, Yoel Kloog, PhD, Jeremy Q Wen, PhD, MD, John Crispino, PhD, Michael D. Radmacher, Guido Marcucci, MD, Clara D. Bloomfield, MD, Shai Izraeli, MD
Journal: Blood
Blood (2009) 114 (22): 475.
https://doi.org/10.1182/blood.V114.22.475.475
Published: 2009